🧬 SinoBioData Academic Portal
Academic Publishing & Life Sciences Intelligence

About SinoBioData

Bridging the gap between cutting-edge Chinese biomedical discoveries, oncology trials, and international biopharmaceutical research institutions.

01

Editorial Mission & Scope

China produces over 25% of the world's global clinical trial data, pioneering breakthroughs in CAR-T cell therapy, Antibody-Drug Conjugates (ADCs), and CRISPR gene editing. However, critical experimental protocols, trial results, and clinical registries often remain published exclusively in high-tier Chinese biomedical repositories.

SinoBioData systematically indexes, peer-reviews, and synthesizes research from elite Chinese medical academies, Chinese Academy of Sciences (CAS) institutes, and top-tier Class-A medical centers, delivering structured takeaways, methodology overviews, and complete authentic PDFs in English for global researchers and life science institutions.

02

Scientific Advisory & Editorial Board

Multidisciplinary academic oversight ensuring clinical accuracy and ethical translation

ICMJE & COPE Aligned

Dr. Robert H. Vance, MD, PhD

Senior Editor

Clinical Oncology & Targeted Biologics

Translational oncology specialist focusing on bispecific antibody efficacy endpoints and Phase I/II clinical trial evaluation.

Dr. Li-Ming Zhao, PhD

Lead Advisor

Genomic Engineering & Stem Cell Therapeutics

Over 15 years research in CRISPR/Cas delivery systems, mesenchymal stem cell secretome analysis, and regenerative cellular medicine.

Dr. Elena Rostova, PharmD, PhD

Regulatory Lead

Pharmacology & Regulatory Bridge Protocols

Expert in NMPA (National Medical Products Administration) regulatory frameworks, pharmacokinetics, and international drug safety harmonization.

Dr. Kevin S. Gallagher, MD

Reviewer

Cellular Immunotherapy & Hematology

Focuses on CAR-T cytokine release syndrome mitigation and real-world clinical safety monitoring in hematologic malignancies.

⚠️Medical & Clinical Information Disclaimer

Professional Academic & R&D Notice: SinoBioData is an independent scientific publication database and translation portal designed strictly for academic researchers, life science professionals, biotechnology developers, and licensed healthcare practitioners. The clinical trial registries, biochemical methodologies, and pharmacological summaries presented on this platform are for technical reference and informational purposes only. Content does not constitute clinical medical advice, diagnostic recommendations, or treatment endorsements. Qualified medical professionals must exercise their independent judgment when evaluating investigational data.